⌘K

Home/Filings/4/0001654954-21-004628

4//SEC Filing

van der Velden Peter 4

Accession 0001654954-21-004628

CIK 0001540159other

View on SEC.gov Company Profile

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 4:55 PM ET

Size

5.0 KB

Accession

0001654954-21-004628

Insider Transaction Report

Form 4

Period: 2021-04-22

Edesa Biotech, Inc.EDSA

van der Velden Peter

Director10% Owner

Transactions

Award
Stock Option (right to buy)
2021-04-22+20,000→ 20,000 total
Exercise: $5.45Exp: 2031-04-22→ Common Shares (20,000 underlying)

Footnotes (1)

[F1]This option vests monthly in equal proportions over 12 months beginning on the Grant Date.

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother

Related Parties

1

filerCIK 0001778046

Filing Metadata

Form type: 4
Filed: Apr 25, 8:00 PM ET
Accepted: Apr 26, 4:55 PM ET
Size: 5.0 KB

View on SEC.gov